Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Roche Holdings ADR RHHBY

Healthcare

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Add To Watchlist

Recent & Breaking News (OTCQX:RHHBY)

Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics

PR Newswire February 9, 2015

FDA Approves Genentech's Lucentis® (Ranibizumab Injection) for Treatment of Diabetic Retinopathy in People With Diabetic Macular Edema

Business Wire February 6, 2015

Genentech's Phase III Study of Gazyva® Showed Significant Benefit in Refractory Indolent Non-Hodgkin's Lymphoma

Business Wire February 4, 2015

FDA Grants Breakthrough Therapy Designation for Genentech's Investigational Cancer Immunotherapy MPDL3280A (Anti-PDL1) in Non-Small Cell Lung Cancer

Business Wire February 2, 2015

Roche and Qualcomm Collaborate to Innovate Remote Patient Monitoring

PR Newswire January 29, 2015

Roche receives FDA clearance for next generation cobas MRSA/SA Test

PR Newswire January 26, 2015

Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients

PR Newswire January 21, 2015

A First in North America: CDL Laboratories acquire the latest technology in laboratory analysis from Roche Diagnostics

Canada NewsWire January 15, 2015

Human Longevity, Inc. Signs Agreement with Genentech for Whole Genome Sequencing and Analysis of Samples

PR Newswire January 14, 2015

Roche licenses additional EGFR pathway-related intellectual property to QIAGEN

PR Newswire January 14, 2015

Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology

Business Wire January 12, 2015

ATHENA data publication reinforces new interim guidance from medical societies on use of HPV as first-line test in cervical cancer screening

PR Newswire January 8, 2015

Xenon Pharmaceuticals Outlines Key Anticipated Milestones for 2015

GlobeNewswire January 8, 2015

23andMe and Genentech to Analyze Genomic Data for Parkinson's Disease

PR Newswire January 6, 2015

Theralase Anti-Cancer Technology Picks Up Steam

Accesswire January 6, 2015

Roche receives FDA Emergency Use Authorization for the LightMix® Ebola Zaire rRT-PCR Test

PR Newswire December 29, 2014

FDA Approves Gazyva® (Obinutuzumab) Supplemental Biologics License Application with New Data in Previously Untreated Chronic Lymphocytic Leukemia

Business Wire December 24, 2014

Roche launches next-generation viral load assay for CMV in markets accepting the CE mark

PR Newswire December 22, 2014

Bina Technologies is acquired by Roche.

PR Newswire December 19, 2014

Roche acquires Bina Technologies and enters the genomic informatics market

PR Newswire December 19, 2014